메뉴 건너뛰기




Volumn 8, Issue 7-8, 2011, Pages 4-7

Current challenges in the development of novel cell-based medicinal products

Author keywords

Advanced therapy medicinal product (ATMP); Cell based medicinal product (CBMP); Committee for advanced therapies (CAT); Current good manufacturing practice (cGMP); EMA working parties; Marketing authorisation; Somatic cell therapy; Tissue engineering

Indexed keywords

ARTICLE; ATMOSPHERE; IMMUNOTOXICITY; KNOWLEDGE; LEGAL ASPECT; MEDICINE; MUTAGENESIS;

EID: 80052827726     PISSN: 17428955     EISSN: None     Source Type: Trade Journal    
DOI: None     Document Type: Article
Times cited : (7)

References (24)
  • 1
    • 11144260473 scopus 로고    scopus 로고
    • Regulation (EC) No 1394/2007 of the European Parliament and of the Council of 13 November 2007 on advanced therapy medicinal products and amending Directive 2001/83/EC and Regulation (EC) No 726/2004, L 324/121 of 10 December
    • Regulation (EC) No 1394/2007 of the European Parliament and of the Council of 13 November 2007 on advanced therapy medicinal products and amending Directive 2001/83/EC and Regulation (EC) No 726/2004. Official Journal of the European Union, L 324/121 of 10 December 2007
    • (2007) Official Journal of the European Union
  • 2
    • 11144260473 scopus 로고    scopus 로고
    • Commission Directive 2009/120/EC of 14 September 2009 amending Directive 2001/83/EC of the European Parliament and of the Council on the Community code relating to medicinal products for human use as regards advanced therapy medicinal products, L 242/3 of 15 September
    • Commission Directive 2009/120/EC of 14 September 2009 amending Directive 2001/83/EC of the European Parliament and of the Council on the Community code relating to medicinal products for human use as regards advanced therapy medicinal products. Official Journal of the European Union, L 242/3 of 15 September 2009
    • (2009) Official Journal of the European Union
  • 4
    • 67049086482 scopus 로고    scopus 로고
    • Novel maxillary reconstruction with ectopic bone formation by GMP adipose stem cells
    • K Mesimäki, B Lindroos, J Törnwall et al. 'Novel maxillary reconstruction with ectopic bone formation by GMP adipose stem cells' (2009), Int J Oral Maxillofac Surg, 38(3):201-9.
    • (2009) Int J Oral Maxillofac Surg , vol.38 , Issue.3 , pp. 201-209
    • Mesimäki, K.1    Lindroos, B.2    Törnwall, J.3
  • 5
    • 33847256045 scopus 로고    scopus 로고
    • Progress and opportunities for tissue-engineered skin
    • S McNeil. 'Progress and opportunities for tissue-engineered skin' (2007), Nature, 445: 874-880
    • (2007) Nature , vol.445 , pp. 874-880
    • McNeil, S.1
  • 6
    • 65649096887 scopus 로고    scopus 로고
    • Articular Cartilage Tissue Engineering: Today's Research, Tomorrow's Practice?
    • A Getgood, R Brooks, L Fortier, N Rushton. 'Articular cartilage tissue engineering: today's research, tomorrow's practice?' (2009), J Bone Joint Surg Br, 91-B: 565-576
    • (2009) J Bone Joint Surg Br , vol.91 , pp. 565-576
    • Getgood, A.1    Brooks, R.2    Fortier, L.3    Rushton, N.4
  • 7
    • 77952523353 scopus 로고    scopus 로고
    • The Oncogenic Potential of Mesenchymal Stem Cells in the Treatment of Cancer: Directions for Future Research
    • E N Momin, G Vela, H A Zaidi, A Quiñones-Hinojosa. 'The Oncogenic Potential of Mesenchymal Stem Cells in the Treatment of Cancer: Directions for Future Research', (2010) Curr Immunol Rev, 6(2):137-148.
    • (2010) Curr Immunol Rev , vol.6 , Issue.2 , pp. 137-148
    • Momin, E.N.1    Vela, G.2    Zaidi, H.A.3    Quiñones-Hinojosa, A.4
  • 8
    • 77649194372 scopus 로고    scopus 로고
    • Challenges with advanced therapy medicinal products and how to meet them
    • C K Schneider et al. 'Challenges with advanced therapy medicinal products and how to meet them', (2010) Nat Rev Drug Discov, 9(3):195-201
    • (2010) Nat Rev Drug Discov , vol.9 , Issue.3 , pp. 195-201
    • Schneider, C.K.1
  • 9
    • 0003975349 scopus 로고    scopus 로고
    • Directive 2001/20/EC of the European Parliament and of the Council of 4 April 2001 on the approximation of the laws, regulations and administrative provisions of the Member States relating to the implementation of good clinical practice in the conduct of clinical trials on medicinal products for human use, L121/34 of 1 May
    • Directive 2001/20/EC of the European Parliament and of the Council of 4 April 2001 on the approximation of the laws, regulations and administrative provisions of the Member States relating to the implementation of good clinical practice in the conduct of clinical trials on medicinal products for human use, Official Journal of the European Communities, L121/34 of 1 May 2001
    • (2001) Official Journal of the European Communities
  • 10
    • 80052868633 scopus 로고    scopus 로고
    • Annex 13: Investigational Medicinal Products., Medicinal Products for Human and Veterinary Use
    • Annex 13: Investigational Medicinal Products. EU Guidelines to Good Manufacturing Practice, Medicinal Products for Human and Veterinary Use. http://ec.europa.eu/health/files/eudralex/vol-4/2009_06_annex13.pdf
    • EU Guidelines to Good Manufacturing Practice
  • 11
    • 80052868633 scopus 로고    scopus 로고
    • Annex 1: Manufacture of Sterile Medicinal Products, Medicinal Products for Human and Veterinary Use
    • Annex 1: Manufacture of Sterile Medicinal Products. EU Guidelines to Good Manufacturing Practice, Medicinal Products for Human and Veterinary Use. http://ec.europa.eu/health/files/eudralex/vol-4/2008_11_25_gmp-an1_en.pdf
    • EU Guidelines to Good Manufacturing Practice
  • 12
    • 11144260473 scopus 로고    scopus 로고
    • Directive 2004/23/EC of the European Parliament and of the Council of 31 March 2004 on setting standards of quality and safety for the donation, procurement, testing, processing, preservation, storage and distribution of human tissues and cells, L 102/48 of 7 April
    • Directive 2004/23/EC of the European Parliament and of the Council of 31 March 2004 on setting standards of quality and safety for the donation, procurement, testing, processing, preservation, storage and distribution of human tissues and cells. Official Journal of the European Communities, L 102/48 of 7 April 2004.
    • (2004) Official Journal of the European Communities
  • 13
    • 58149400832 scopus 로고    scopus 로고
    • Use of humanized severe combined immunodeficient mice for human vaccine development
    • G C Koo, A Hasan, R J O'Reilly. 'Use of humanized severe combined immunodeficient mice for human vaccine development', Expert Rev Vaccines, 2009 Jan;8(1):113-20.
    • (2009) Expert Rev Vaccines , vol.8 , Issue.1 , pp. 113-120
    • Koo, G.C.1    Hasan, A.2    O'Reilly, R.J.3
  • 15
    • 77952582258 scopus 로고    scopus 로고
    • Overcoming the hurdles of randomised clinical trials of therapeutic cancer vaccines
    • T Sasada, N Komatsu, S Suekana et al. 'Overcoming the hurdles of randomised clinical trials of therapeutic cancer vaccines', (2010) Eur.J.Cancer 46: 1514-1519.
    • (2010) Eur.J.Cancer , vol.46 , pp. 1514-1519
    • Sasada, T.1    Komatsu, N.2    Suekana, S.3
  • 16
    • 79953151733 scopus 로고    scopus 로고
    • Modelling opportunities in comparative oncology for drug development
    • I K Gordon, C Khanna. 'Modelling opportunities in comparative oncology for drug development', (2010), ILAR J. 51 (3)214-220.
    • (2010) ILAR J , vol.51 , Issue.3 , pp. 214-220
    • Gordon, I.K.1    Khanna, C.2
  • 17
    • 79958162790 scopus 로고    scopus 로고
    • 'Human relevance of pre-clinical studies in stem cell therapy; systematic review and metaanalysis of large animal models of ischemic heart disease'
    • T I van der Spoel, S J Jansen Of Lorkeers, P Agostoni et al. 'Human relevance of pre-clinical studies in stem cell therapy; systematic review and metaanalysis of large animal models of ischemic heart disease', Cardiovasc Res. online 14 April 2011.
    • (2011) Cardiovasc Res. Online , pp. 14
    • van der Spoel, T.I.1    Jansen Of Lorkeers, S.J.2    Agostoni, P.3
  • 19
    • 84945897159 scopus 로고    scopus 로고
    • Directive 2010/63/EU of the European Parliament and of the Council of 22 September
    • Directive 2010/63/EU of the European Parliament and of the Council of 22 September 2010, On the protection of animals used for scientific purposes.
    • (2010) On the Protection of Animals Used For Scientific Purposes
  • 20
    • 38549090588 scopus 로고    scopus 로고
    • Cardiac Cell Therapy In Vitro: Reproducible Assays for Comparing the Efficacy of Different Donor Cells
    • R Klinger, N Bursac. 'Cardiac Cell Therapy In Vitro: Reproducible Assays for Comparing the Efficacy of Different Donor Cells', (2008), Eng Med BiolMag. 27(1): 72-80
    • (2008) Eng Med BiolMag , vol.27 , Issue.1 , pp. 72-80
    • Klinger, R.1    Bursac, N.2
  • 21
    • 80052868122 scopus 로고    scopus 로고
    • EMEA/CHMP/CPWP Guideline on Human Cell-based Medicinal Products EMEA/CHMP/410869/
    • EMEA/CHMP/CPWP Guideline on Human Cell-based Medicinal Products EMEA/CHMP/410869/2006.
    • (2006)
  • 22
    • 80052842187 scopus 로고    scopus 로고
    • EMEA/CHMP/CPWP Concept paper on the development of a guideline on the risk-based approach according to annex I, part IV of directive 2001/83/EC applied to advanced therapy medicinal products CHMP/CPWP/708420/09
    • EMEA/CHMP/CPWP Concept paper on the development of a guideline on the risk-based approach according to annex I, part IV of directive 2001/83/EC applied to advanced therapy medicinal products CHMP/CPWP/708420/09
  • 23
    • 80052835997 scopus 로고    scopus 로고
    • http://www.tigenix.com/en/objects/docs/newsroom/press_releases/2011/110224_TiGenix_Press_Release_Reimbursement_Belgium.pdf
  • 24
    • 80051830687 scopus 로고    scopus 로고
    • Committee for Advanced Therapies (CAT), EMA/CAT/235374/
    • Committee for Advanced Therapies (CAT) Work Programme 2010-2015 (EMA/CAT/235374/2010).
    • (2010) Work Programme 2010-2015


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.